Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic Cancer
Clinical trial NCT02558868 · COMPLETED
Trial details
- NCT number
- NCT02558868
- Sponsor
- Zhejiang University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-09-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.